MST-188-04 - Evaluation of repeat administration of Purified Poloxamer 188 in vaso-occlusive crisis of Sickle Cell Disease (EPIC-E): An open-label safety extension trial assessing repeat administration of MST-188 (Purified Polo

Project: Research project

Project Details

StatusFinished
Effective start/end date8/3/1510/31/16

Funding

  • Mast Therapeutics, Inc.
  • Mast Therapeutics, Inc.